|
gptkbp:instance_of
|
gptkb:drug
|
|
gptkbp:bfsLayer
|
4
|
|
gptkbp:bfsParent
|
gptkb:Isaac_H._Cho
gptkb:Robert_L._Smith
gptkb:Greg_Sanders
gptkb:Celgene
gptkb:Dr._Thomas_H._Müller
gptkb:Jack_W._Wilson
gptkb:Timothy_A._Mc_Gowan
gptkb:Cheryl_A._Mc_Gowan
|
|
gptkbp:aims_to
|
genetic disorders
|
|
gptkbp:can_be_used_with
|
other treatments
|
|
gptkbp:delivers
|
therapeutic proteins
viral vectors
non-viral methods
|
|
gptkbp:developed_by
|
gptkb:psychologist
Huntington's disease
cardiovascular diseases
|
|
gptkbp:focuses_on
|
gptkb:hospital
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Gene Therapy
|
|
gptkbp:is_associated_with
|
gptkb:CRISPR_technology
RNA interference
gene editing
|
|
gptkbp:is_capable_of
|
mutated genes
|
|
gptkbp:is_discussed_in
|
patient safety
cost-effectiveness
clinical efficacy
biomedical ethics
|
|
gptkbp:is_influenced_by
|
scientific advancements
regulatory policies
technological innovations
|
|
gptkbp:is_involved_in
|
altering genes
inserting genes
knocking out genes
|
|
gptkbp:is_often_depicted_as
|
gene editing
|
|
gptkbp:is_part_of
|
precision medicine
|
|
gptkbp:is_studied_in
|
gptkb:healthcare_organization
gptkb:cystic_fibrosis
gptkb:sickle_cell_disease
gptkb:DJ
|
|
gptkbp:is_used_for
|
gptkb:healthcare_organization
viral infections
inherited diseases
|
|
gptkbp:is_used_in
|
preventive medicine
|
|
gptkbp:is_vulnerable_to
|
immune response
insertional mutagenesis
|
|
gptkbp:legal_issue
|
germline modifications
|
|
gptkbp:occupation
|
gptkb:hospital
|
|
gptkbp:performed_by
|
clinical trials
|
|
gptkbp:regulates
|
health authorities
|
|
gptkbp:research
|
the 1970s
|
|
gptkbp:specifies
|
patients
|
|
gptkbp:subject
|
policy making
public debate
scientific publications
medical conferences
public health discussions
|
|
gptkbp:technique
|
gene delivery
|
|
gptkbp:treatment
|
gptkb:ADA_deficiency
gptkb:Leber's_congenital_amaurosis
certain diseases
|
|
gptkbp:type_of
|
gptkb:Company
|
|
gptkbp:uses
|
gptkb:physicist
|